Cadence Brings Proven Leadership to Rural Health Transformation Program As states begin implementing the Rural Health Transformation Program (RHTP), Cadence is positioned as the leading provider of scalable, outcomes-driven remote care for seniors with chronic disease across rural America. With…
New Life Sciences Survey Reveals Traditional Personalization Models Fail to Build Trust and Motivate Patients Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today released a report based on in-depth surveys…
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision medicine in brain health, today announced enrollment of the first…
WellSky® Introduces AI-Powered Summarization Technology for Personal Care WellSky, a leading health and community care technology company, today announced the launch of WellSky Summarize for Personal Care, a new AI-powered solution that delivers concise summaries of client care information for…
Doc.com Files for Nasdaq Listing as It Advances Global Expansion of Its AI-Powered, Blockchain-Secured Healthcare Platform Doc.com Inc., a pioneering healthcare technology company dedicated to democratizing access to quality healthcare, today announced that it has submitted an application for a proposed…
GHOST®, Cinnamon Toast Crunch™ and Lucky Charms™ Team Up to Deliver Protein-Packed Cereals Get ready to level up your breakfast game! General Mills, in continued collaboration with lifestyle and sports nutrition brand GHOST®, is thrilled to announce the launch of two new crave-worthy,…
SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-specific Gene Expression for in vivo Gene Therapies SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch…
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and…
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is intended for use…
New Report Reveals Americans Are Getting Sick More Often, Earlier in Life UnitedHealthcare and Health Action Council (HAC), a nonprofit employer coalition, today released their ninth annual white paper highlighting emerging health trends linked to workforce health and affordability. Based…
Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based nasal sprays to prevent influenza infection…
Federal Court Grants WHOOP Preliminary Injunction Against Lexqi WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co.,…